BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6191706)

  • 1. [Clinical experiences with pepleomycin].
    Furue H; Komita T; Mugitani H; Fuse K; Hakozaki M; Kobayashi H; Takahashi T; Hirota F; Yoshihira T
    Gan To Kagaku Ryoho; 1982 May; 9(5):930-5. PubMed ID: 6191706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of non-Hodgkin's lymphoma with NK-631 (peplomycin)--with special reference to the effect on T and non-T cell lymphomas].
    Kamihira S; Jinnai I; Kinoshita K; Ichimaru M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):289-92. PubMed ID: 6191697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical use of peplomycin in esophageal cancer].
    Hirai T; Takiyama W; Miyoshi Y; Hattori T; Yamagata S; Ohya M
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1249-55. PubMed ID: 6191710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effect of Peplomycin on recurrent breast cancer].
    Kimura M; Koida T; Fukuda T
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1665-9. PubMed ID: 6191688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of clinical studies of pepleomycin.
    Oka S
    Recent Results Cancer Res; 1980; 74():163-71. PubMed ID: 6160600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiotherapy combined with pepleomycin administration for the treatment of esophageal cancer].
    Koyama S; Togo J; Miyamoto J; Nakahara A; Kawakita I; Shibata H; Yamagata S; Muto H; Fukutomi H; Sakita T; Ohara K; Akisada M
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1562-7. PubMed ID: 6191719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Side effects of peplomycin].
    Araki Y; Tamura K; Seita M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2446-50. PubMed ID: 2425749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II trial of peplomycin in non-Hodgkin's lymphoma].
    Sampi K; Kumai R; Hattori M; Kaneko Y; Sakurai M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1063-7. PubMed ID: 2581513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pepleomycin in prostatic cancer. A preliminary report.
    Niijima T; Koiso K
    Scand J Urol Nephrol Suppl; 1980; 55():177-9. PubMed ID: 6163206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy with peplomycin and carboquone (esquinon) for squamous cell carcinoma of the lung].
    Negoro S; Fukuoka M; Takada M; Tamai S; Sakai N; Matsui K
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):522-8. PubMed ID: 6191699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z; Koketsu H; Nakajima T; Niitani H
    Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of peplomycin in squamous cell carcinoma of the lung.
    Sørensen PG; Rørth M; Hansen HH; Dombernowsky P; Høst H
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):25-7. PubMed ID: 6189718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antineoplastic drug-induced pneumonitis-fibrosis].
    Oizumi K; Nakai Y; Konno K
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1217-24. PubMed ID: 6206254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of PEP bleomycin studies in Japan.
    Ikeda S; Miyasato H; Nakayama H; Tajima K; Sato A
    Recent Results Cancer Res; 1981; 76():41-60. PubMed ID: 6165056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous subcutaneous infusion of peplomycin in oral squamous carcinoma].
    Kanazawa H; Takahashi K; Hanazawa Y; Uchiyama S; Takahara T; Takahara M; Muto M; Kinehara M; Sato K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):775-80. PubMed ID: 2469396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of Bleomycin in tumor pateints].
    Rieche K; Matthias M
    Arch Geschwulstforsch; 1973; 41(3):232-40. PubMed ID: 4126058
    [No Abstract]   [Full Text] [Related]  

  • 17. [A phase II clinical trial of pepleomycin].
    Feng F; Zhang H
    Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):388-91. PubMed ID: 9387284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment for advanced malignant lymphoma in patients with compromised bone marrow--a combination therapy using pepleomycin, vincristine and high-dose adrenocorticoids (POP regimen)].
    Tamura K; Araki Y; Seita M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2568-72. PubMed ID: 6210054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro and in vivo antitumor effects of pepleomycin alone or in combination with radiation.
    Sakamoto K; Komatsu K; Matsumoto Y
    Radiat Res; 1985 May; 102(2):224-31. PubMed ID: 2416000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect of peplomycin in cervical cancer, with special reference to pathohistological studies].
    Noda K; Sugawa T; Kurihara S; Suzuki M; Akiya K; Ueda K; Takamizawa H; Fukuda T; Chihara T; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1983 Oct; 18(7):1921-31. PubMed ID: 6200550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.